Change: 1.15 %Chge: 0.74% Vol: 90,695
VRTX Chart
You need Flash Player to see the chart, please download from the link below
Related Healthcare and Pharmaceuticals Companies
| Steris |
92.61
|
6,422 |
| Bio Rad Labs |
124.57
|
7,314 |
| Medtronic |
87.08
|
436,072 |
| Celgene |
119.93
|
197,611 |
| Gilead Sciences |
72.67
|
372,480 |
| Brookdale Sr Living |
22.43
|
114,092 |
| Johnson & Johnson |
136.5
|
251,605 |
| Humana |
128.95
|
49,385 |
Above is a small selection of related companies to Vertex Pharmaceuticals which compete alongside VRTX within the Healthcare and Pharmaceuticals sector. To see more related companies to VRTX, view our stock market today information page.
Online News For Vertex Pharmaceuticals
VRTX Crosses Above Key Moving Average Level
In trading on Friday, shares of Vertex Pharmaceuticals, Inc. (Symbol: VRTX) crossed above their 200 day moving average of $155.31, changing hands as high as $157.53 per share. Vertex Pharmaceuticals, Inc. shares are currently trading up about 3.8% on the day.
Vertex Pharmaceuticals Incorporated (VRTX) Rises 3.28% for May 11
Among the biggest risers on the S&P 500 on Friday May 11 was Vertex Pharmaceuticals Incorporated ($VRTX), popping some 3.28% to a price of $155.97 a share with some 2.23 million shares trading hands. Starting the day trading at $150.75, Vertex ...
Are Analysts Bullish Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) After Last Week?
Investors sentiment decreased to 1.34 in 2017 Q4. Its down 0.28, from 1.62 in 2017Q3. It turned negative, as 53 investors sold Vertex Pharmaceuticals Incorporated shares while 160 reduced holdings. 72 funds opened positions while 213 raised stakes.
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) 2017 Q4 Sentiment Report
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) institutional sentiment decreased to 1.34 in 2017 Q4. Its down -0.28, from 1.62 in 2017Q3. The ratio turned negative, as 285 investment professionals increased or started new equity positions, while 213 sold and ...
Biotech Stock Roundup: ALXN, VRTX Post Solid Results, GILD Disappoints in Q1
The Biotech space remained a key area of investors focus as several bigwigs announced quarterly results. While Alexion (ALXN - Free Report) reported solid results, Gilead (GILD - Free Report) reported dismal numbers. Among other developments over the week ...
Want To Add This Quote To Your Site?
With our stock widgets you can add a Vertex Pharmaceuticals quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for VRTX to choose from. Visit here to build your stock quote widget »
